Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
A private biopharmaceutical company focused on the development of therapies for retinal dystrophies. NightStar Therapeutics was acquired by Biogen in June 2019.
Incorporated in January 2014
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs. In the first instance the focus will be on, the detection and the accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states in these organs.
Incorporated in April 2013
Origin: Oxford University, Department of Cardiovascular Medicine
Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.
Incorporated in July 2012
Origin: Oxford University, Institute of Biomedical Engineering
Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.
Incorporated in October 2010
Origin: Oxford University, Department of Engineering Science